<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1256</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2007-0-2-26-29</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак мочевого пузыря</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Organ-preserving surgery for the upper urinary tract malignancy</article-title><trans-title-group xml:lang="ru"><trans-title>Органосохраняющие операции при опухолях верхних мочевыводящих путей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Komyakov</surname><given-names>B. K.</given-names></name><name xml:lang="ru"><surname>Комяков</surname><given-names>Б. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Saint Petersburg</p></bio><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Guliyev</surname><given-names>B. G.</given-names></name><name xml:lang="ru"><surname>Гулиев</surname><given-names>Б. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Saint Petersburg</p></bio><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Karlov</surname><given-names>P. A.</given-names></name><name xml:lang="ru"><surname>Карлов</surname><given-names>П. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Saint Petersburg</p></bio><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>El-Atar</surname><given-names>T.</given-names></name><name xml:lang="ru"><surname>Эль-Атар</surname><given-names>Т.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Saint Petersburg</p></bio><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Unit of Urology, Municipal Multidisciplinary Hospital Two</institution></aff><aff><institution xml:lang="ru">Урологическое отделение городской многопрофильной больницы №2</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2007-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2007</year></pub-date><volume>3</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>26</fpage><lpage>29</lpage><history><date date-type="received" iso-8601-date="2020-02-27"><day>27</day><month>02</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-02-27"><day>27</day><month>02</month><year>2020</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/1256">https://oncourology.abvpress.ru/oncur/article/view/1256</self-uri><abstract xml:lang="en"><p>The results of organ-preserving interventions are analyzed in 12 patients (7 males and 5 females) with neoplasms of the renal pelvis and ureter. Endoscopic operations were performed in 4 patients with the normally functioning contralateral kidney and in one patient with the single kidney. Early complications developed in 2 of the 12 patients and were infectious and inflammatory. The mean duration of endoscopic surgery was 32.8±4.9 min; intraoperative blood loss is 83.0±15.3 ml; the duration of open surgery averaged 157.2±29.7 min and intraoperative blood loss was 1930±69.3 ml. After 4 years of a follow-up, the frequency of tumor relapse was 40%; 5-year survival was 80%. Thus, in patients with upper urinary tract neoplasms, organ-preserving operations are a justifiable alternative to nephroureterectomy with urinary bladder resection and most reasonable in uni- and bilateral renal tumor. Urinary tract endoscopic examination assessing the possibilities of freely manipulating an endoscope in the ureteral lumen and renal cavitary system for biopsy of a tumor and its further removal is a major and determining factor in defining indications for this type of intervention.</p></abstract><trans-abstract xml:lang="ru"><p>The results of organ-preserving interventions are analyzed in 12 patients (7 males and 5 females) with neoplasms of the renal pelvis and ureter. Endoscopic operations were performed in 4 patients with the normally functioning contralateral kidney and in one patient with the single kidney. Early complications developed in 2 of the 12 patients and were infectious and inflammatory. The mean duration of endoscopic surgery was 32.8±4.9 min; intraoperative blood loss is 83.0±15.3 ml; the duration of open surgery averaged 157.2±29.7 min and intraoperative blood loss was 1930±69.3 ml. After 4 years of a follow-up, the frequency of tumor relapse was 40%; 5-year survival was 80%. Thus, in patients with upper urinary tract neoplasms, organ-preserving operations are a justifiable alternative to nephroureterectomy with urinary bladder resection and most reasonable in uni- and bilateral renal tumor. Urinary tract endoscopic examination assessing the possibilities of freely manipulating an endoscope in the ureteral lumen and renal cavitary system for biopsy of a tumor and its further removal is a major and determining factor in defining indications for this type of intervention.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Карякин О.Б. Опухоли лоханки и мочеточника. В кн.: Клиническая онкоурология. Б.П. Матвеев (ред.). М., Вердана; 2003. с. 175—94.</mixed-citation><mixed-citation xml:lang="ru">Карякин О.Б. Опухоли лоханки и мочеточника. В кн.: Клиническая онкоурология. Б.П. Матвеев (ред.). М., Вердана; 2003. с. 175—94.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Матвеев Б.П., Фигурин К.М. Диагностика опухолей верхних мочевых путей. Урол и нефрол 1998;(5):29—34.</mixed-citation><mixed-citation xml:lang="ru">Матвеев Б.П., Фигурин К.М. Диагностика опухолей верхних мочевых путей. Урол и нефрол 1998;(5):29—34.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Переверзев А.С. Хирургия опухолей верхних мочевых путей. Харьков, Факт; 1997.</mixed-citation><mixed-citation xml:lang="ru">Переверзев А.С. Хирургия опухолей верхних мочевых путей. Харьков, Факт; 1997.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Комяков Б.К., Идрисов Ш.Н., Новиков А.И. и др. Оперативное лечение эпителиальных опухолей верхних мочевыводящих путей. Урология 2004;(4):12—6.</mixed-citation><mixed-citation xml:lang="ru">Комяков Б.К., Идрисов Ш.Н., Новиков А.И. и др. Оперативное лечение эпителиальных опухолей верхних мочевыводящих путей. Урология 2004;(4):12—6.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Матвеев Б.П., Фигурин К.М. Лечение опухолей верхних мочевых путей (ретроспективный анализ). Урол и нефрол 1988;(6):41—4.</mixed-citation><mixed-citation xml:lang="ru">Матвеев Б.П., Фигурин К.М. Лечение опухолей верхних мочевых путей (ретроспективный анализ). Урол и нефрол 1988;(6):41—4.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Люнгрен Е., Коллберг С., Штенер Б. Замещение мочеточника выключенной петлей тонкой кишки. Урол и нефрол 1962;(1):43—8.</mixed-citation><mixed-citation xml:lang="ru">Люнгрен Е., Коллберг С., Штенер Б. Замещение мочеточника выключенной петлей тонкой кишки. Урол и нефрол 1962;(1):43—8.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Комяков Б.К. Диагностика и оперативное лечение опухолей верхних мочевых путей. Урол и нефрол 1998;(3):18—21.</mixed-citation><mixed-citation xml:lang="ru">Комяков Б.К. Диагностика и оперативное лечение опухолей верхних мочевых путей. Урол и нефрол 1998;(3):18—21.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Fernandez Gomez J., Sampietro Crespo A., Fernandez Duran A. et al. Segment resection of the ureter in transitional cell carcinoma. Arch Esp Urol 1995;48(4):393—5.</mixed-citation><mixed-citation xml:lang="ru">Fernandez Gomez J., Sampietro Crespo A., Fernandez Duran A. et al. Segment resection of the ureter in transitional cell carcinoma. Arch Esp Urol 1995;48(4):393—5.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Anderstrom C., Johansson S., Petersson S., Wahlqvist L. Carcinoma of the ureter: a clinicopathology study of 49 cases. J Urol 1989;149(2):1231—8.</mixed-citation><mixed-citation xml:lang="ru">Anderstrom C., Johansson S., Petersson S., Wahlqvist L. Carcinoma of the ureter: a clinicopathology study of 49 cases. J Urol 1989;149(2):1231—8.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Лопаткин Н.А., Мартов А.Г., Ергаков Д.В. Эндоскопические методы диагностики и лечения папиллярных опухолей верхних мочевыводящих путей. Урология 2001;36:46—51.</mixed-citation><mixed-citation xml:lang="ru">Лопаткин Н.А., Мартов А.Г., Ергаков Д.В. Эндоскопические методы диагностики и лечения папиллярных опухолей верхних мочевыводящих путей. Урология 2001;36:46—51.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Jabour M., Desgrandchamps F., Cazin S. et al. Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome. J Urol 2000;163(4):1105—7.</mixed-citation><mixed-citation xml:lang="ru">Jabour M., Desgrandchamps F., Cazin S. et al. Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome. J Urol 2000;163(4):1105—7.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Keeley F., Bibbo M., Bagley D. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 1997;157(5):1560—5.</mixed-citation><mixed-citation xml:lang="ru">Keeley F., Bibbo M., Bagley D. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol 1997;157(5):1560—5.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Geavlete P., Jora T. A ureteral endoscopic approach-a minimally invasive method complementary to nephroureterectomy. Chirurgia 1998;93(2):107—14.</mixed-citation><mixed-citation xml:lang="ru">Geavlete P., Jora T. A ureteral endoscopic approach-a minimally invasive method complementary to nephroureterectomy. Chirurgia 1998;93(2):107—14.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Elliott D.S., Blute, M.L., Patterson D.E. et al. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology 1996;47(6):819—25.</mixed-citation><mixed-citation xml:lang="ru">Elliott D.S., Blute, M.L., Patterson D.E. et al. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology 1996;47(6):819—25.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
